Fig. 3.
Mean (SE) haemolytic markers from baseline (BL) to week 79, then last on-treatment visit with available assessment (LV). a) lactate dehydrogenase [LDH], b) reticulocyte count, c) haptoglobin. Only non-missing values are considered. LV is the last on-treatment visit with available assessment. PBO, placebo. SE, standard error. SUT, sutimlimab.